EGFR and cancer: Particularly interesting was the observation that the focal amplifications of receptor tyrosine kinases, including ERBB2, EGFR, MET, FGFR1 and FGFR2, are markedly more frequent in esophageal adenocarcinomas (42%) than in gastric (28%) and colorectal (14%) cancers [62].